UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Science (American Association for the Advancement of Science), 2013-05, Vol.340 (6136), p.1113-1117

2013

Volltextzugriff (PDF)

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

Nature medicine, 2010-01, Vol.16 (1), p.123-128

2010

Volltextzugriff (PDF)

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance

PloS one, 2016-10, Vol.11 (10), p.e0165047-e0165047

2016

Volltextzugriff (PDF)

Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice

PloS one, 2010-10, Vol.5 (10), p.e13137

2010

Volltextzugriff (PDF)

721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A431-A432

2020

Volltextzugriff (PDF)

Antigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5

PloS one, 2011-04, Vol.6 (4), p.e17189

2011

Volltextzugriff (PDF)

STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation

The Journal of immunology (1950), 2008-04, Vol.180 (7), p.4805-4815

2008

Volltextzugriff (PDF)

Abstract 532: A patient-derived anti-CD9 antibody induces tumor rejection and synergistically enhances anti-PD1 activity

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.532-532

2020

Volltextzugriff (PDF)

A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13), p.3372-3382

2019

Volltextzugriff (PDF)

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Blood, 2020-11, Vol.136 (Supplement 1), p.41-42

2020

Volltextzugriff (PDF)

Immunohistochemical demonstration of l-serine distribution in the rat brain

Neuroreport, 2001-04, Vol.12 (5), p.1027-1030

2001

Volltextzugriff (PDF)

Abstract 542: T-cell engager bispecific formats of an AML patient-derived antibody targeting a unique sialylated CD43 epitope induce kill of melanoma cells in vitro and in vivo

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.542-542

2020

Volltextzugriff (PDF)

Abstract 531: AT1412, a patient-derived antibody in development for the treatment of CD9-positive precursor B-acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.531-531

2020

Volltextzugriff (PDF)

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Blood, 2018-01, Vol.131 (1), p.131-143

2018

Volltextzugriff (PDF)

An antibody derived from a cured AML patient to identify a unique epitope on CD43 (CD43s) as a novel target for acute myeloid leukemia and myelodysplastic syndrome

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7009-7009

2017

Volltextzugriff (PDF)

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.4461-4461

2019

Volltextzugriff (PDF)

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Blood, 2015-12, Vol.126 (23), p.5473-5473

2015

Volltextzugriff (PDF)

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood, 2016-12, Vol.128 (22), p.1646-1646

2016

Volltextzugriff (PDF)

Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus

Journal of immunological methods, 2018-03, Vol.454, p.15-26

2018

Volltextzugriff (PDF)

Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire

Methods (San Diego, Calif.), 2014-01, Vol.65 (1), p.38-43

2014

Volltextzugriff (PDF)

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Blood, 2014-12, Vol.124 (21), p.3826-3826

2014

Volltextzugriff (PDF)

Erratum: Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Nature medicine, 2016-12, Vol.22 (12), p.1502-1502

2016

Volltextzugriff (PDF)

Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

Nature medicine, 2016-12, Vol.22 (12), p.1502-1502

2016

Volltextzugriff (PDF)

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Blood, 2015-12, Vol.126 (23), p.3146-3146

2015

Volltextzugriff (PDF)

Cellular Localization of Group IIA Phospholipase A2 in Rats

The journal of histochemistry and cytochemistry, 2001-06, Vol.49 (6), p.777-782

2001

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Englisch
(149)
Japanisch
(76)

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(81)
Humans
(71)
Male
(37)
Female
(30)
Animals
(25)
Middle Aged
(22)
Adult
(18)
Biochemistry & Molecular Biology
(18)
Biological And Medical Sciences
(14)
Physical Sciences
(12)
Aged
(11)
Chemistry
(11)
Mice
(11)
Cardiovascular System & Cardiology
(10)
Fundamental And Applied Biological Sciences. Psychology
(10)
Molecular Sequence Data
(10)
Base Sequence
(9)
Cell Biology
(9)
Neurosciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance

Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice

721 AT1412, a patient-derived CD9 antibody in preclinical development promoting tumor immune infiltration and inducing tumor rejection

Antigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5

STAT3-Mediated Up-Regulation of BLIMP1 Is Coordinated with BCL6 Down-Regulation to Control Human Plasma Cell Differentiation

Abstract 532: A patient-derived anti-CD9 antibody induces tumor rejection and synergistically enhances anti-PD1 activity

A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Immunohistochemical demonstration of l-serine distribution in the rat brain

Abstract 542: T-cell engager bispecific formats of an AML patient-derived antibody targeting a unique sialylated CD43 epitope induce kill of melanoma cells in vitro and in vivo

Abstract 531: AT1412, a patient-derived antibody in development for the treatment of CD9-positive precursor B-acute lymphoblastic leukemia

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

An antibody derived from a cured AML patient to identify a unique epitope on CD43 (CD43s) as a novel target for acute myeloid leukemia and myelodysplastic syndrome

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus

Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Erratum: Corrigendum: Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Cellular Localization of Group IIA Phospholipase A2 in Rats

Suchergebnisse filtern